Aster DM Health. Cash flow Statement
Figures in Rs cr
Consolidated Cash Flow Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
No of Months
12
12
12
12
12
12
Profit Before Tax
330.00
535.00
636.00
205.00
330.00
412.00
Adjustment
1,570.00
1,269.00
1,136.00
1,179.00
1,136.00
664.00
Changes In working Capital
-1,671.00
87.00
-401.00
195.00
-177.00
-422.00
Cash Flow after changes in Working Capital
229.00
1,892.00
1,371.00
1,580.00
1,288.00
654.00
Cash Flow from Operating Activities
157.00
1,833.00
1,314.00
1,569.00
1,223.00
600.00
Cash Flow from Investing Activities
-878.00
-950.00
-563.00
-333.00
-658.00
-702.00
Cash Flow from Financing Activities
1,052.00
-817.00
-686.00
-1,116.00
-674.00
134.00
Net Cash Inflow / Outflow
332.00
65.00
64.00
119.00
-109.00
32.00
Opening Cash & Cash Equivalents
365.00
299.00
234.00
114.00
224.00
191.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
697.00
365.00
299.00
234.00
114.00
224.00
Compare Cash Flow Results of Aster DM Health.
Figures in Rs cr
consolidated Cash Flow Results
Change(INR)
Change(%)
Profit Before Tax
330.3
449.29
-119.00
-26.48%
Adjustment
1570.03
198.55
1,372.00
690.75%
Changes In working Capital
-1671.26
102.82
-1,773.00
-1725.42%
Cash Flow after changes in Working Capital
229.07
750.66
-521.00
-69.48%
Cash Flow from Operating Activities
157.81
644.52
-487.00
-75.52%
Cash Flow from Investing Activities
-878.25
-342.34
-536.00
-156.54%
Cash Flow from Financing Activities
1052.83
345.64
707.00
204.60%
Net Cash Inflow / Outflow
332.39
647.81
-315.00
-48.69%
Opening Cash & Cash Equivalents
365.07
119.43
246.00
205.68%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
697.46
767.24
-70.00
-9.09%
Cash Flow - Snapshot (Consolidated) - Mar'24
YoY Growth in year ended Mar 2024 is -91.40% vs 39.57% in Mar 2023
Mar'24
Mar'23
Change(%)
Cash Flow from Operating Activities
157.81
1,833.98
-91.40%